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Abstract
The ethical, legal, and social implications (ELSI) of emerging neurobiobanks and data resources are unclear in an African scientific
landscape with unique cultural, linguistic, and belief systems. The overarching goal of the African Neurobiobank for Precision
Stroke Medicine–—ELSI Project is to identify, examine, and develop novel approaches to address ELSI issues of biobanking and
stroke genomic research in sub-Saharan Africa (SSA). To accomplish the goal we will (1) explore knowledge, attitude,
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perceptions, barriers, and facilitators influencing ELSI issues related to biobanking and stroke genomic research; (2) use infor-
mation obtained to craft a community intervention program focused on ELSI issues; and (3) build capacity and careers related to
genomics and biobanking for effective client/community engagement while enhancing regulatory, governance, and implementation
competences in biobanking science in SSA. A community-based participatory research and mixed-methodological approach,
focused on various levels of the social ecological model, will be used to identify and examine relevant ELSI issues. Contextual
intervention tools, platforms, and practices will be developed to enhance community understanding and participation in stroke
biobanking and genomics research activities while facilitating enduring trust, and equitable and fair utilization of biobanking
resources for genetic and trans-omics research. A concurrent capacity building program related to genetic counseling and
biobanking will be implemented for early career researchers. The huge potential for neurobiobanking and genomics research in
Africa to advance precision medicine applicable to stroke and other neurological disorders requires addressing ELSI challenges
while building sustainable research, career, and regulatory capacities in trans-omics and biobanking science.
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Background
Africa has historically been underrepresented in the biobank-
ing revolution (Vaught, 2016a, 2016b). However, with the
Human, Heredity and Health in Africa (H3Africa) Initiative
biorepository science has been bolstered and biobanking-
related activities are growing on the continent (Abimiku
et al., 2017; Akinyemi et al., 2018; Mayne et al., 2017). Bio-
banking is a rapidly evolving field of biomedical science that
involves the collection, processing, storage, and distribution
of biospecimens along with creating necessary policies and
procedures for each stage of the process. Although initially
focused on collecting samples for diagnostic purposes in
pathology settings, biobanks have since evolved into orga-
nized repositories and networks that are now engaged in
cutting-edge translational research, which form the bedrock
of personalized (or precision) medicine. Neurobiobanking
derives its uniqueness in the storage of data from brain
images, clinical neurological information, and neural tissue
in addition to other biological materials stored by other kinds
of biobanks. However, organized neurobiobanking is still bur-
geoning in sub-Saharan Africa (SSA) with the Stroke Inves-
tigative Research and Education Network (SIREN) Biobank
(Akinyemi et al., 2018) and the IBADAN Brain Bank (Aki-
nyemi, Salami, et al., 2019) representing pioneering efforts in
the region.
In SSA, stroke persists as a leading cause of death, disabil-
ity, and dementia with incidence rates rising, outcomes worse
than those found in higher income countries, and relatively
younger people affected compared to White populations (Eze-
jimofor et al., 2017; Owolabi et al., 2015). Developing trans-
omics approaches to predict, prevent, diagnose, and treat stroke
in the framework of current emphasis on precision/persona-
lized medicine (Collins & Varmus, 2015; Hewitt, 2011)
requires a clear understanding of the interplay of environmental
and genomic risk factors (Akinyemi et al., 2016; Owolabi et al.,
2017). The substantial genetic diversity of African populations
offers a unique opportunity to identify novel genes and mole-
cular pathways (Xu et al., 2017); hence, the National Institutes
of Health–funded SIREN (Akpalu et al., 2015) has focused on
furthering understanding of the environmental and genetic risk
factors for stroke in SSA and, in the process, has developed a
robust biobank of invaluable brain imaging data and human
tissue resources, including blood and its fractions (serum,
plasma, buffy coat, and red cell concentrates) and genetic mate-
rials (DNA) (Akinyemi et al., 2018). In addition, the IBADAN
Brain Bank Project, the first organized brain bank in Africa, has
emerged to accrue brain tissue for future complementary trans-
omic studies (Akinyemi, Salami, et al., 2019). However, the
ethical, legal, and social implications (ELSI) of the developing
neurobiobank and data resources are unclear in an emerging
African scientific landscape with unique cultural, linguistic,
and belief systems operating in a global “open science”
research community that increasingly supports the principles
of trust, openness, storage, sharing, and secondary use of bio-
logical materials (Bledsoe, 2017). The huge potential for neu-
robiobanking in Africa to advance precision stroke medicine
(Hinman et al., 2017) requires that important ELSI issues be
addressed while building sustainable research and regulatory
capacity, careers, and infrastructure in trans-omics and bio-
banking science.
Biobanking and Precision Stroke Medicine
Precision medicine (often used interchangeably with persona-
lized medicine) is broadly described as treatments targeted to
the needs of individual patients on the basis of genetic, biomar-
ker, phenotypic, or psychosocial characteristics that distinguish
a given patient from other patients with similar clinical pre-
sentation (Collins & Varmus, 2015; Hewitt, 2011). The pur-
pose of precision medicine is to ensure that the patient gets the
right treatment, at the right dose, at the right time, with mini-
mum ill consequences and maximum efficacy. Precision stroke
medicine (Hinman et al., 2017) involves the acquisition of
multiple data sets including clinical phenotype, biological data
(genomic, blood biomarkers), imaging data, and data integra-
tion (bioinformatic analysis, systems biology, and modeling
including artificial intelligence) toward individualized
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diagnosis and treatment, as well as prediction of recurrence
risk, medication effects, procedural outcomes, and stroke
recovery. Biological samples stored in a biobank provide
resources to generate biological data (omics data sets), which
contribute to the process of delivering tailored interventions
(Hewitt, 2011). For instance, gene expression profiling based
on interrogation of RNA molecules circulating in peripheral
blood has already demonstrated promise in differentiating
stroke from acute nonstroke conditions and in differentiating
subtypes (Hinman et al., 2017). Genomic study of stroke
among Africans presents a unique opportunity for the discov-
ery, validation, fine mapping and functional annotation, and
translation of genomic determinants of stroke with implications
for global populations (Owolabi et al., 2017).
Scientific Gaps in the ELSI of Neurobiobanking and
Stroke Genomics in Africa
Genomic and biobanking–based research is increasingly being
conducted in the context of collaborations between researchers
in high-income countries and those in low- and middle-income
countries (LMICs) (Munung et al., 2017). Although African
researchers now have unique opportunities to contribute to
cutting-edge stroke genomic research, existing ethical, legal,
and regulatory frameworks have also been challenged (de Vries
et al., 2016, 2017; Tindana & de Vries, 2016). Gaps exist in the
key ELSI elements of biobanking, including informed consent
(broad, blanket, restricted, and tiered), respect, trust building,
privacy, confidentiality, sample reuse and sharing, feedback of
results, community engagement (CE), governance, and capac-
ity strengthening related to neurobiobanking and stroke geno-
mics research in SSA. The key question is: How do we enhance
sustainable, equitable, and trustworthy use of stored biological
samples and pragmatically put genomics and other biomarker
data therefrom to beneficial use in the best interest of the public
and scientists in SSA? In particular, the ELSI surrounding
emerging stroke biobank and data resources and ELSI princi-
ples that should govern return of individual results and inci-
dental findings of stroke genomic research in SSA remain
unclear. Additionally, there does not seem to be culturally
appropriate, context-relevant, sustainable tools available for
addressing the ELSI of neurobiobanking, and stroke genomics
research in the region. Certainly, original, region-based,
evidence-driven exploration and intervention into ELSI of neu-
robiobanking and stroke genomics in SSA is urgently required.
Study goal. The overarching goal of the African Neurobiobank
for Precision Stroke Medicine—ELSI Project is to identify,
examine, and develop novel approaches to address ELSI issues
of stroke genomics and biobanking in SSA. The project will
develop novel, context-relevant, and culturally appropriate
interventions to enhance community understanding and partic-
ipation in stroke genomic and biobanking activities in an equi-
table, trusting, and fair space while building sustainable careers
in genetic counseling and biobanking science.
Theoretical frameworks for the African Neurobiobank for Precision
Stroke Medicine ELSI Project. The guiding theoretical frame-
works for the project are the social ecological model (SEM;
Young et al., 2006), evidence-based community partnership
model (EBCPM; Coughlin & Jenkins, 2017; Wells et al.,
2004), the Six Steps in Quality Intervention Development
(SQuID; Wight et al., 2016), implementation cycle (IC; Owo-
labi et al., 2016), and the RE-AIM Framework (Glasgow &
Estabrooks, 2018; Harden et al., 2018). Participants in the
research are viewed through the lens of the SEM and
community-based participatory research (CBPR; Coughlin
& Jenkins, 2017), while the processes of development and
implementation of the novel interventions are based on the
SQuID (Wight et al., 2016), EBCPM (Wells et al., 2004), and
IC (Owolabi et al., 2016). We have also adopted the Reach,
Effectiveness–Adoption, Implementation, Maintenance (RE-
AIM) framework to enable the team to comprehensively eval-
uate the processes of our interventions and accomplishments
(Sweet et al., 2014). Figure 1 shows the overall organizational
plan of the project, while Table 1 provides further details on the
guiding frameworks.
Methodological Approach
This project uses a CBPR (Coughlin & Jenkins, 2017) and
mixed-methodological approach involving the various levels
of the SEM: (a) individual/patient; (b) family/significant
other caregiver; (c) healthcare/organizations, traditional/
faith healers, hospital administrators, and ethics committee
members; and (d) the community (Young et al., 2006). The
SEM will help identify and examine relevant ELSI issues
and develop novel, context-relevant, and culture-appropriate
interventions. A key concept in CBPR is identifying and
collaborating with community partners to meet local needs
and priorities that build toward a sustainable and equitable
academic and community partnership (Israel et al., 2013).
Our study continues work from the existing SIREN study
and CBPR by enhancing community partnerships and
expanding efforts to establish ELSI-specific Community
Advisory Boards (CABs). Using CBPR approaches will
enable us to engage with community partners, enhance com-
munity input, and identify community-specific preferences
and approaches toward ELSI neurobiobanking and stroke
genomic research.
Settings, Sites, and Study Population
The project will recruit stroke survivors, caregivers, healthy
controls, providers, hospital administrators, researchers, public
health practitioners, ethics committee members, and laypersons
from seven sites within the established SIREN from commu-
nities in southern (Abeokuta and Ibadan), central (Ilorin), and
northern (Kano and Zaria) Nigeria and southern (Accra) and
central (Kumasi) Ghana (Table 2). Ethical approval will be
sought from the institutional review board of each site and
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informed consent from each participant in the focused ethno-
graphy and questionnaire survey.
CAB and CE
A CAB (Guidance Tools for CABs, 2012; Newman et al.,
2011) will be formed in each community consisting of six to
nine members (minimum) at each study site, consistent with
CBPR principles. The membership will be comprised of stroke
survivor(s), faith-based leader(s), community leader(s), public
health leader(s), ethics committee representative(s), and
profession-based organizational leader(s), including the media
and legal practice. Potential CAB members will be approached
by the study CE coordinators at each site through personal
contact from an existing pool of key community members
residing in the SIREN study areas. The CABs will serve as a
Figure 1. Organizational plan for the African Neurobiobank for Precision Stroke Medicine ethical, legal, and social implication.
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Table 1. Theoretical and Model Underpinnings and Standardized Definitions.
Model/Theory Description Application
Social ecological model (SEM) SEM constructs are used to explore individual
and population health related to biobanking
and stroke genomics including individual
factors (e.g., genetics, individual knowledge,
beliefs, behaviors, consent, privacy,
confidentiality, return of results, and incidental
findings), interpersonal factors (e.g., family,
friends, peers, benefit sharing, and return of
results), institutional processes (e.g.,
governance and regulatory framework,
biobank networks, and social support
systems), and community factors (e.g.,
relationships among networks, biobanking
governance), and public policy (e.g., local,
state, and national laws/policies on
biobanking).
Provides overall framework for organizing our
research. Each participant is viewed through the
lens of the SEM. The SEM will guide the
development of the focused ethnography (FE)
within Aim 1, with in-depth interviews with
stroke survivors and formal and informal
caregivers, researchers, public health
practitioners, community leaders, faith leaders,
traditional healers, and lay public. The survey
research methodology will incorporate
information from the FE related to the SEM and
will guide Aim 2.
Evidence-based community/
partnership model (EBCPM)
The EBCPM process is designed to implement
community-based participatory research and
evidence-based practice “to support health
improvement goals through evidence-based
strategies while building community and practice
capacity to implement those strategies in a
manner consistent with community priorities,
culture, and values.”
The EBCPM will be operationalized within Aims
1 and 2 in parts. Step 1 will include
negotiation of goals among local community
stakeholders, practices, and researchers
(already done in planning grant proposal). Step
2 will include active involvement of the
Biobanking Community Advisory Board (CAB)
to guide researchers and actively participate in
engaging the community in process. This will
be done by matching community needs,
resources, and values with evidence-based
practice strategies to address unmet needs
and tailor these to the community contexts
(Aim 2).
Six Steps in Quality Intervention
Development (SQuID)
The SQuID is a six-step process-based approach
used to guide researchers in developing high-
quality interventions. Steps: (1) Defining and
understanding the problem and its causes, (2)
clarifying which causal or contextual factors
are malleable and have greatest scope for
change, (3) identifying how to bring about
change and change mechanism, (4) identifying
how to deliver change mechanism, (5) testing
and refining on small scale, and (6) collecting
sufficient evidence of effectiveness to justify
rigorous evaluation/implementation.
The six steps are used for capturing the process for
development of the proposed interventions (in
combination with the EBCPM). Given the scope
of this work, pretesting/testing will be limited. FE
and survey will incorporate Steps 1–4 (Aims 1 and
2), and Aim 2 will focus on Steps 2–5. Application
of Step 6 will be tested in future grant.
Implementation cycle (IC) The IC is a seven-step process that involves
identification and exploration of evidence gaps
and subsequent development, contextualization,
communication of evidence-based consensus
interventions to combat cardiovascular diseases
in LMICs. It also entails the evaluation of the
processes and outcomes involved. The cycle
includes a Translatability Scale to grade the ease
of implementation especially in resource-limited
settings.
The seven steps of the IC are adaptable to the
processes of African Neurobiobank Precision
Stroke Medicine ELSI Project. Aim 1 of our
project is in tandem with Steps A and B of the
cycle, while Aim 2 aligns with Steps C–G of
the IC. The training component (Aim 3) of the
project will ensure an adequate supply of
expertise for effective implementation,
evaluation and scaling up the interventions
tools, and platforms for wider population-
based impact.
(continued)
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community liaison at each of the seven sites and will guide the
investigators in explaining research to the local residents and
facilitate the recruitment of participants, sustainable and
responsive interactions with the community as well as facilitat-
ing feedback of research findings back to the community. Ini-
tial meetings/discussions will be held with the CAB members
to ensure that they understand the goals of the study, strengthen
community–academic partnerships, and facilitate stakeholders’
input into the operations and programs of CE and the research
processes.
Specific Aim 1: To identify and examine ethical, legal, and
social issues relating to stroke biobanking in the context of
African research landscape, culture, and beliefs. We will
explore knowledge, attitude, perceptions, barriers, and facil-
itators influencing ELSI-related to the use of blood and
blood fractions in the context of stroke genomic research.
The research questions will be explored using a mixed qua-
litative (focused ethnography; Higginbottom et al., 2013)
and quantitative (questionnaire survey) approach and focus
on the key issues of the ELSI of donating blood for research,
storage, reuse of stored blood fractions, and return of indi-
vidual research results and incidental findings.
Plan to Accomplish Specific Aim 1
Qualitative approach. Focus group discussions (FGDs) and key
informant interviews (KIIs) will be conducted following the
guidance of Higginbottom et al. (2013). To develop the inter-
view guidance notes, we reviewed the peer-reviewed literature
related to the ELSI of neurobiobanking and genomic research
as well as lay literature available to the communities. The
research team further reviewed and refined the interview
guides to ensure the aforementioned research questions are
appropriately captured. Interview prompts include a social eco-
logical perspective (i.e., patient, family/caregiver, health sys-
tems [including traditional healers], and community factors;
Green et al., 1996; Young et al., 2006). The FGDs will explore
the perspectives of the ELSI CABs members, stroke patients,
stroke caregivers, and stroke-free laypersons, while the KIIs
will explore the views of sampled researchers, health care
Table 1. (continued)
Model/Theory Description Application
Reach, Effectiveness-Adoption,
Implementation, Maintenance
(RE-AIM) framework for
Evaluation
RE-AIM provides a functional framework for
assessing the public health impact of health
promotion strategies. Evaluative criteria include:
Reach assesses the percentage, and
characteristics of individuals within population
who participate in a program; effectiveness
explores positive and negative programmatic
outcomes; adoption encompasses the number,
percentage, and representativeness of program
participants in relation to the overall population
of interest; implementation is an indicator of the
extent of program delivery, adherence, and cost;
and maintenance reflects sustained adoption/
adherence of the primary outcomes (>6 months)
at the individual level and sustainability of
delivered programs at an organizational level.
We will use RE-AIM to evaluate the overall African
Neurobiobank for Precision Stroke Medicine:
Ethical Legal Social Implications (ELSI) Project.
Specifically, REACH will be used to capture the
numbers of investigator, trainee, and community
participants in the project. Community
participation will include CAB participation as
well as community members participating in
various aspects of the program. EFFECTIVENESS
will be operationalized to capture both the
negative and positive effects/outcomes for
investigators and trainees, and the communities.
Adoption process and outcome evaluation will
include measurement of number of settings,
organizations, trainees, and community members
that actively participate in our ELSI project.
Implementation will measure the overall and
specific activities implemented as planned.
Maintenance will examine the changes or
outcomes that are potentially “lasting outcomes”
or changes as a result of ELSI activities. We will
specifically examine (1) new ELSI-related
knowledge regarding stroke genomics and
biobanking; (2) novel interventions to address the
ELSI issues so identified; (3) processes, outcomes,
and impact of the interventions; (4) training early
career researchers in ELSI research and practice;
and (5) enhanced capacity of ethics committees
to deal with ELSI issues in new research projects
being developed in biobanking, genomics, and
precision stroke medicine according to the
various levels of SEM and RE-AIM frameworks.
Note. LMIC ¼ low- and middle-income countries.
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providers, public health practitioners, hospital administrators,
and religious and community leaders on key ELSI elements of
neurobiobanking. These ELSI elements include informed con-
sent (broad, blanket, restricted, or tiered), trust, privacy and
confidentiality, ownership, sample storage and secondary use,
feedback of research results (general and individual) and inci-
dental findings, governance, and regulatory issues (Bledsoe,
2017) within the context of stroke genomic research. Similar
approaches have been used in previous studies exploring per-
spectives of laypersons about biobanking (Igbe &Adebamowo,
2012) and of research participants about use of biological sam-
ples (Moodley et al., 2014).
FGDs. Trained interviewers will conduct FGDs at SIREN
participating site settings described in Table 2. Each FGD will
include six to eight participants to sustain a meaningful but
guided discussion and four FGDs will be conducted per site.
Respective FGDs will be comprised of (1) site CAB members,
(2) stroke survivors previously enrolled in SIREN, (3) their
primary caregivers, and (4) stroke-free laypersons who have
not been previously enrolled in SIREN. Participants will be
selected by purposive sampling (maintaining careful balance
for age, gender, socioeconomic status, and types/levels of dis-
abilities and caregiver support distribution, as appropriate)
until no new data related to biobanking ELSI are identified
(saturation). Participants will be 18 years and older and have
no condition that could limit FGD participation, such as cog-
nitive impairment/dementia (Brief Community Screening
Interview for Dementia (CSID) score < 6; Prince et al., 2011)
and severe global disability (modified Rankin score  3; Owo-
labi, Akinyemi, Gebregziabher, et al., 2014; Owolabi, Aki-
nyemi, Hurst, et al., 2014). We will conduct the sessions with
Table 2. Participating Sites.
Site Description
Korle Bu Teaching Hospital (KBTH), Accra, Ghana This is a 1,500-bed tertiary hospital serving as the main referral hospital of the
Southern part Ghana and the capital Accra. Stroke is the leading cause of
admissions to the medical wards of the KBTH with a high case fatality rate.
There is currently an ongoing collaboration to improve stroke care in the
Wessex–Ghana stroke project.
Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana KATH is the second largest hospital in the country (*1,000 beds) and the only
tertiary health institution in the Ashanti Region, located in Kumasi, Ghana. It is
the main referral hospital for the Ashanti, Brong Ahafo, Northern, Upper East
and Upper West Regions. It is the teaching hospital affiliated to the medical
school of the Kwame Nkrumah University of Science and Technology (KNUST),
also located in Kumasi. Stroke also forms a major cause of admission at KNUST
with mortality rates of up to 30%.
The University College Hospital (UCH) and Blossom
Center for Neurorehabilitation, Ibadan, Nigeria
UCH has 850 bed spaces and 163 examination couches. The hospital is a tertiary
institution with several affiliated community care centers where the hospital
offers secondary and primary health care. Blossom Center for
Neurorehabilitation was established in 2010 through the support of the World
Federation for Neurorehabilitation as the first center for Neurorehabilitation in
East, West, and Central Africa.
The Federal Medical Center (FMC), Abeokuta, Nigeria and
Sacred Heart Hospital, Abeokuta
FMC is a 250-bed regional tertiary center established in April 1993. It receives
patients from Ogun and neighboring states and countries and relates closely
with community care clinics within and outside the Abeokuta metropolis. The
Sacred Hospital Abeokuta is the oldest missionary community hospital in
Nigeria focusing on underserved communities in the subregion.
Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria AKTH hospital is a tertiary referral health center established in 1988 for Kano
state and its neighboring states like Jigawa, Katsina, Zamfara, Bauchi, Gombe,
and Yobe.
The Ahmadu Bello University Teaching hospital, Zaria,
Nigeria
It is located in Zaria, Northern Nigeria, and consist of three sites located in Kaduna
and Zaria (in Kaduna State), and Malumfashi (in Katsina State), with a total bed
capacity of 768. It remains a major referral center for the 19 Northern States but
receives patients predominantly from the Northwestern States of Kaduna,
Katsina, Zamfarad Kano, and adjoining Northcentral States of Niger, Kogi, and
Nassarawa, including Abuja, the Federal Capital.
University of Ilorin Teaching Hospital (UITH), Ilorin,
Nigeria
UITH is a 550-bed hospital with 130 beds for medical inpatients, of which 10 are
dedicated to acute stroke care. This is in addition to 23 beds for medical
emergencies. Between 20 and 30 stroke cases are admitted per month and most
of these are managed in a dedicated acute stroke care unit. The hospital is
equipped with CT and MRI scanners while carotid Doppler studies and cardiac
Holter monitoring are also available for patients who require these. In addition,
the hospital provides community-based primary health care services in three
adjoining states, namely, Esie in Kwara, Ihima in Kogi, and Kishi in Oyo states.
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a member of the ELSI team taking field notes (video and/or
audio). Written consent will be obtained from participants prior
to the start of any session. The interviews will occur at a loca-
tion convenient to participants. Methods developed by Trem-
blay (2002) will guide interview processes. All interviews,
along with field notes and audio/video (as appropriate), will
be recorded and audio transcribed verbatim for qualitative
analysis.
KIIs. Interviews will be carried out with health care providers
(doctors, nurses, pharmacists, medical laboratory scientists,
medical records personnel, and other allied health workers),
health administrators, religious and community leaders, and
traditional healers using semistructured qualitative inquiry.
Approximately 10 participants from each SIREN participating
site will be recruited. A KII protocol and specific questions will
be developed to guide the discussion regarding key ELSI ele-
ments of neurobiobanking focusing on the key research ques-
tions. Participants in the KIIs will also be “purposively
sampled” from the various stakeholder groups. However, such
interviewees will be with persons with demonstrable interest
and/or work experience with patients with stroke. Regarding
religious leaders, we will liaise with the CAB of the SIREN
participating sites to identify relevant religious leaders repre-
senting the major faith blocs (Christianity, Islam, and Tradi-
tional Religion).
Qualitative data management, analyses, and reporting. All data
will be uploaded and stored on REDCap (Harris et al., 2009), a
secure data storage system. Transcripts of the audio recordings
and field notes will be used for data analysis. Transcriptions
will be compared with recordings to confirm accuracy and
authenticity. The transcripts will be imported into the text anal-
ysis software (i.e., NVivo, version 9.0) for data management
and analyses. For the initial analysis of the data, we will review
the transcripts and undertake the process of (a) coding for
descriptive labels, (b) sorting for patterns, (c) identification
of outliers or negative cases, (d) generalizing the constructs
and theories, and (e) conduct memoing, including reflective
remarks (Miles et al., 2013). Saturation of data will be deter-
mined when no new descriptive labels are identified. The
“framework analysis” approach (Srivastava & Thomson,
2009) will be used and it includes five key stages: familiariza-
tion, identifying a thematic framework, indexing, charting,
mapping, and interpretation to meet the processes of Steps 1
and 2 and partially address Step 3 of the 6 SQuID (Wight et al.,
2016). To maintain and evaluate rigor, reliability and validity
issues in qualitative studies are best addressed as trustworthi-
ness, which are dependent on credibility, confirmability, trans-
ferability, and dependability (Shenton, 2004).
Quantitative approach (questionnaire survey)
Design. Drawing lessons from the approaches of Jallinoja
and colleagues (Jallinoja & Aro, 1999; Jallinoja & Aro,
2000), Moodley et al. (2014), and Yamamoto et al. (2017), as
well as key highlights of the pilot phase of the project, we will
develop a survey questionnaire to elicit demographic
information and perspectives on elements of the key study
questions: ELSI of donating blood for research, storage and
secondary use of stored blood and blood fractions, and prefer-
ence for return of individual research results and incidental
findings within the context of stroke genomics research. We
will explore the association of factors that might influence
respondents’ perspectives: “demographic data,” “genetic
knowledge,” “cultural and religious beliefs,” “health-
conscious behaviors,” and “communication with health
professionals” (Yamamoto et al., 2017). For “genetic knowl-
edge,” we will utilize the genetic knowledge questionnaire
developed by Jallinoja et al. (2000).
Health conscious behavior type questions will deal with
regular physical activity, eating a healthy diet, and intention-
ally reducing alcohol intake and/or smoking. Questions con-
cerning communication with health professionals seek to assess
whether participants have a health care provider for consulta-
tion regarding their health checkup results. Participant’s pre-
ferences on receiving individual research results and incidental
findings will be explored in relation to the following types of
conditions: lifestyle diseases, pharmacogenetics, adult-onset
clinically actionable diseases, and adult-onset nonclinically
actionable diseases (multiple answers possible; Yamamoto
et al., 2017). The questionnaire will be pretested in a non-
SIREN hospital site and further refined in a FGD. FGD parti-
cipants will be asked about readability, comprehension, and
cultural appropriateness of questionnaire items. Data from
FGDs will allow further questionnaire refinement. We will
invite sampled SIREN participants via telephone (cases and
controls) to complete the survey questionnaire, while non-
SIREN laypersons will be recruited through in-person CE
activities at their respective sites. Questionnaires will be admi-
nistered by trained interviewers and written informed consent
will be obtained prior to completion of the survey.
Questionnaire survey (sample size, power calculation, and
statistical analysis). The survey will be conducted in SIREN
participating sites (Table 2) and involve 1,000 SIREN-
enrolled stroke survivors, 1,000 SIREN-enrolled stroke-free
controls, and 1,000 non-SIREN stroke-free laypersons. Includ-
ing diverse perspectives will allow the examination of the
influence of previous contact with the SIREN study as well
as stroke disease status on the key ELSI outcome measures
being explored. Survey sample numbers are estimated based
on preliminary data, which showed 48.7% of stroke patients
and 57.0% of stroke-free individuals have knowledge of stroke
heritability (Akinyemi, Sarfo, et al., 2019). Using these as a
premise and with a 3% degree of precision and 95% confidence
level, 829 stroke-free controls would be required. Adjusting for
85% anticipated response rate, the effective sample size is
estimated to be 975. The survey is targeted at capturing the
knowledge, attitude, behavior, and practice (KABP) of the
three distinct groups (SIREN stroke survivors, SIREN-
enrolled stroke-free controls, and non-SIREN stroke-free lay-
persons) with similar sample size estimations for these three
groups, yielding an average of 1,000 per group across all sites.
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The number of participants to be surveyed per site will be
proportionate to the size of SIREN recruitment from each site.
Respondents will be selected by stratified random sampling
using the recruitment list as sampling frame.
Data analysis. Descriptive statistics will be used to summar-
ize the demographic and other variables. For hypothesis test-
ing, w2 or Fisher’s exact test will be used to investigate factors
associated with KABP regarding genetic testing. p Values of
.05 will be considered statistically significant. The Mann–
Whitney U test will be used to analyze ranked responses
including participants’ preferences for receiving genetic test
results. To identify the independent factors associated with the
outcomes, logistic regression models with robust (clustered)
standard error will be fitted to adjust for clustering or within-
site correlations. Data analysis results from the survey will be
triangulated with the results of analyses of the qualitative data
sets to provide input into the process of designing interventions
in Specific Aim 2.
Specific Aim 2: To use information obtained from Aim 1 to
craft a novel intervention program to address the ELSI
issues related to stroke genomic and biobanking research
in SSA using the CBPR and a multimodal approach (to
target different components of the SEM).
Plan to Accomplish Specific Aim 2
The key goal of this specific aim is to develop contextual
interventions to enhance community understanding and partic-
ipation in neurobiobanking activities in an environment where
there is enduring trust and equitable and fair utilization of
biobanking resources for genetic and trans-omics research to
enhance precision medicine using stroke as a model. Interven-
tion development and pretesting will focus on working with the
CAB and a purposively selected group of researchers, post-
stroke patients, families, community members, health care pro-
viders, faith-based organizations, and regulatory bodies. The
overarching purpose of this group will be to integrate findings
from Aim 1 to develop and refine culturally and scientifically
relevant intervention strategies and incorporate potential varia-
tions across regions/sites.
Development of intervention tools. Our team has prior experience
producing a documentary on stroke suitable for the lay public
(Akinyemi et al., 2015; Owolabi, Akinyemi, Gebregziabher,
et al., 2014). We will employ our knowledge from this experi-
ence and work with communication experts, as well as techni-
cal partners, to produce high-quality materials. These materials
will be reviewed by the CAB and research team members for
input and further refinement. Using themes and content details
synthesized from the outputs of Specific Aim 1, we will
develop short, novel, and informative training videos, comics,
and case vignettes on neurobiobanking, genomics, and preci-
sion medicine with an emphasis on the associated ethical, legal,
and societal issues (Table 3). During the developmental stages
of the intervention tools, we will ask SIREN stroke patients,
stroke caregivers, SIREN stroke-free control subjects, and
stroke-free laypersons (four Nigerians and four Ghanaians for
each category) to view the videos and provide feedback via
semistructured interviews and narratives. We plan to adapt
Doak and Doak’s Suitability Assessment Measure (Doak
et al., 1994; Weintraub et al., 2004) to help us evaluate the
tools along with the semistructured interview prompts based
on Willis’s cognitive interviewing techniques (Willis, 2004;
Willis & Miller, 2011). This feedback will inform further
refinements of the tools to ensure they are contextually rele-
vant, culturally sensitive, and can be clearly understood by
those viewing the materials.
CE, dissemination, and implementation. Using our previously
developed IC framework (Owolabi et al., 2016), we will imple-
ment a multilevel CE program for deployment of each interven-
tion tool and platform and collect measurable outcome data.
Furthermore, as part of our CBPR approach, we will engage
with relevant professional organizations and groups to develop
and refine current biobanking guidelines, as applicable to neu-
robiobanking. Workshops and seminars will be organized target-
ing early career researchers (ECRs), members of the research
community, ethics committee members, policy makers, public
health practitioners, and health administrators to promote aware-
ness and understanding of ELSI related to neurobiobanking,
genomics, and precision medicine. Given our prior experience
with this type of deployment, we anticipate a robust impact.
Specific Aim 3: To build capacity and careers related to
ELSI of genomic (genetic counselors) and biobanking (bio-
bank scientists), to enhance regulatory (ethics committees)
and implementation competencies in biobanking science in
SSA.
Plan to Accomplish Specific Aim 3
A prime goal of the H3Africa program is capacity building for
the next generation of African researchers and professionals to
use genomic approaches to advance health research. In line
with this vision, our project is designed to facilitate the growth
of ECRs and ethics committee members drawn from the study
sites in ELSI related to neurobiobanking, genomics, and preci-
sion medicine through training workshops and seminars. From
the cohort of ECRs, four talented and highly motivated ECRs
will be competitively selected for advanced training. The focus
on genetics and genomics (two genetic counselors) and bio-
banking science (two biobank scientists/managers) will ensure
that advanced competencies are acquired by these emerging
leaders to handle ELSI-related issues including governance,
sample use and storage, genomic and biobanking education,
effective client/CE, international sample and data sharing, and
other emerging ELSI issues. The program is designed with
sufficient exposure to training in ELSI related to biobanking,
genomics, and precision medicine. Specific components of the
training include (i) responsible conduct of research; (ii)
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informed consent; (iii) biosample reuse; (iv) biorights; (v) data
sharing; (vi) CBPR focused on building the capacity of the
researchers to work effectively with our communities; (vii)
qualitative and quantitative research processes and analyses;
(viii) genetic, genomic, and phenomic research; (ix) statis-
tical analysis; (x) genetic epidemiology and phenotyping;
(xi) bioinformatics; and (xii) mentoring. After the training,
the project will facilitate continued support and institutiona-
lized mentoring of the ECRs through the Centre for Geno-
mic and Precision Medicine at the College of Medicine,
University of Ibadan, Nigeria. Group, peer, and one-on-
one mentoring models will be facilitated with the local and
international faculty as well as consultants on the project.
The training program will also enhance regulatory and gov-
ernance competencies of health research ethics committee
members across study sites in dealing with ELSI-related
matters of genetics/genomics and biobanking science in
SSA. By this, the project will greatly enhance capacity for
ELSI research in Africa and initiate a favorable trajectory of
successive generations of highly trained African personnel
within this important field.
Evaluation of the Interventions
To assess the processes and outcomes of the intervention, we
will adapt the RE-AIM model (Glasgow & Estabrooks, 2018;
Harden et al., 2018; Sweet et al., 2014) to evaluate the reach,
effectiveness, adoption, implementation, and maintenance of
the novel ELSI tools, platforms, and interventional activities
we develop (Table 3). The use of RE-AIM will enhance the
quality of the evaluation and will be used to evaluate the overall
and specific activities of the ELSI Project. We will use the
“hybrid approach” that is guided by pragmatic decisions
regarding prioritization of strategies that deserve a more thor-
ough RE-AIM evaluation and which are better evaluated using
one or two RE-AIM dimensions described by Glasgow and
colleagues (Glasgow & Estabrooks, 2018; Harden et al., 2018).
Dissemination of Products
Products from this project (videos, vignettes, comics, scholarly
publications, newsletters, policy briefs, etc.) will be dissemi-
nated widely and made available across Africa and globally
Table 3. Novel Intervention Tools and Platforms.
Novel Tool/Platform Goal Target
Biobanking and Personalized Medicine
Community Advisory Board (CAB)
To bridge the academic-community gap an enhance
participant and public education regarding ELSI
related to biobanking and stroke genomics.
Stroke community and general public
Neurobiobank Expert Consensus
Guideline
Government and professional association
sanctioned expert consensus ELSI stroke
biobanking and genomics policy guideline
document to enhance best practices among
professionals involved in biobanking and
genomics research
Stroke community, stroke genomic and
neurobiobank researchers
Biobanking training programs
(workshops, seminars)
To enhance biobanking awareness and
understanding of related ELSI issues
Researchers, ethics committee members, policy
makers, public health practitioners, health
administrators, and CAB members
Biobanking and Precision Medicine
Community Awareness Programs
To promote public understanding regarding
biobanking and stroke genomics ELSI
Faith-based organizations, lay public, print and
electronic media, mHealth technologies, social
media platforms, and film industry such as
Nollywood
Stimulate the establishment of the
African Neurobiobank Network
To provide a platform for regular engagement of
biobank researchers, development of
harmonized guidelines for neurobiobanking in
SSA based on international best practices
Stroke community, stroke genomic, and
neurobiobank researchers
Development of informative video on
neurobiobanking, genomics and
precision medicine
To enhance biobanking, stroke genomics, and
precision medicine literacy and related ELSI
Stroke community (patients and persons at risk,
caregivers, advocates) and lay public
Development of training video on
neurobiobanking and precision
medicine
To enhance biobanking, stroke genomics and
precision medicine literacy and related ELSI
Researchers and academics (stroke, genomics,
biobanking) and ethics committee members
Development of comics and case
vignettes relating to
neurobiobanking, genomics, and
precision medicine
To use comics and case vignettes to illustrate key
ELSI-related scenarios and how to deal with them
Stroke community, lay public, and especially
young people
Capacity training program in genetic
counseling and biobanking science
To develop a crop of professionals with relevant
competences in neurobiobanking and genetic
counseling.
Biomedical scientists, public health professionals,
postgraduate students with relevant
qualifications
Note. ELSI ¼ ethical, legal, and social implications; SSA ¼ sub-Saharan Africa.
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through peer-reviewed publications, scientific conferences,
including the biannual H3Africa Consortium meetings, other
biobanks and CE programs/strategies, regular meetings with
CAB members, electronic, print, and social media, as well as
presenting results at community-based activities. Electronic
versions of all products will be available on the project website.
Translation into local languages will be encouraged for wider
dissemination.
Conclusion
This study will provide currently nonexistent but much-needed
practical tools and interventions for addressing the ELSI of
neurobiobanking and neurogenomics in Africa at several lev-
els, with stroke genomics as a model. It will explore the utiliza-
tion of technology-driven tools that facilitate ready integration
across different tiers of health care facilities and the commu-
nity. Additionally, the approach developed in this project may
serve as a model for addressing neurobiobanking ELSI in
LMICs around the world, and even underresourced areas
within high-income countries, as well as for addressing bio-
banking and genomics ELSI of other chronic diseases. To our
knowledge, this will be the first study to (1) establish a cultu-
rally sensitive, multilevel, systematic effort to explore and doc-
ument ELSI issues relating to neurobiobanking in Africa; (2)
evaluate the impact/influence of stroke genomics ELSI on pre-
cision stroke medicine; (3) develop the first-ever community-
based intervention for neurobiobanking by engaging relevant
stakeholders; (4) implement a neurobiobanking study in Africa
using focused ethnography; (5) develop a capacity building
program for training genetic counselors and biorepository
scientists focused on brain disorders; and (6) strengthen the
development of the first organized brain bank in Africa.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to
the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for
the research, authorship, and/or publication of this article: The African
Neurobiobank for Precision Stroke Medicine ELSI Project, the SIREN
Study, and the Systematic Investigation of Blacks with Stroke using
Genomics (SIBS Genomics) Study are supported by Grants
U01HG010273, U54HG007479, and R01NS107900, respectively,
from the National Institutes of Health as part of the H3Africa Con-
sortium. Rufus O. Akinyemi is further supported by the FLAIR fel-
lowship funded by the UK Royal Society and the African Academy of
Sciences.
ORCID iDs
Rufus O. Akinyemi https://orcid.org/0000-0001-5286-428X
Michelle Nichols https://orcid.org/0000-0002-2078-9649
Joshua Akinyemi https://orcid.org/0000-0002-0675-2110
Musibau Titiloye https://orcid.org/0000-0002-2708-4764
Mayowa Ogunronbi https://orcid.org/0000-0003-4104-2728
Osi Adeleye https://orcid.org/0000-0001-8941-7715
References
Abimiku, A., Mayne, E. S., Joloba, M., Beiswanger, C. M., Troyer, J.,
& Wideroff, L. (2017). H3Africa Biorepository Program: Support-
ing genomics research on African populations by sharing high-
quality biospecimens. Biopreservation and Biobanking, 15(2),
99–102. http://doi.org/10.1089/bio.2017.0005
Akinyemi, R. O., Akinwande, K., Diala, S., Adeleye, O., Ajose, A.,
Issa, K., Owusu, D., Boamah, I., Yahaya, I. S., Jimoh, A. O.,
Imoh, L., Fakunle, G., Akpalu, A., Sarfo, F., Wahab, K., Sanya,
E., Owolabi, L., Obiako, R., Osaigbovo, G., . . .Owolabi, M.
(2018). Biobanking in a challenging African environment:
Unique experience from the SIREN project. Biopreservation and
Biobanking, 16(3), 217–232. http://doi.org/10.1089/bio.2017.
0113
Akinyemi, R. O., Owolabi, M. O., Adebayo, P. B., Akinyemi, J. O.,
Otubogun, F. M., Uvere, E., Adjenijio, O., Adeleye, O., Aridegbe,
O., Taiwo, F. T., Ogun, S. A., & Ogunniyi, A. (2015). Task-
shifting training improves stroke knowledge among Nigerian
non-neurologist health workers. Journal of the Neurological
Sciences, 359(1–2), 112–116. http://doi.org/10.1016/j.jns.2015.
10.019
Akinyemi, R. O., Owolabi, M. O., Oyeniyi, T., Ovbiagele, B., Arnett,
D. K., Tiwari, H. K., Walker, R., Ogunniyi, A., Kalaria, R. N., &
the SIREN group of the H3 Africa Consortium. (2016). Neuroge-
nomics in Africa: Perspectives, progress, possibilities and priori-
ties. Journal of the Neurological Sciences, 366, 213–223. http://
doi.org/10.1016/j.jns.2016.05.006
Akinyemi, R. O., Salami, A., Akinyemi, J., Ojagbemi, A., Olopade, F.,
Coker, M., Farombi, T., Nweke, M., Arulogun, O., Jegede, A.,
Owolabi, M., Kalaria, R. N., & Ogunniyi, A. (2019). Brain banking
in low and middle-income countries: Raison D’etre for the Ibadan
brain ageing, dementia and neurodegeneration (IBADAN) brain
bank project. Brain Research Bulletin, 145, 136–141. http://doi.
org/10.1016/j.brainresbull.2018.08.014
Akinyemi, R. O., Sarfo, F. S., Akinyemi, J., Singh, A., Onoja Akpa,
M., Akpalu, A., Owolabi, L., Adeoye, A. M., Obiako, R., Wahab,
K., Sanya, E., Komolafe, M., Ogbole, G., Fawale, M., Adebayo,
P., Osaigbovo, G., Sunmonu, T., Olowoyo, P., Chukwuonye, I.,
Ovbiagele, B., . . . for the SIREN Investigators. (2019). Knowl-
edge, attitudes and practices of West Africans on genetic studies
of stroke: Evidence from the SIREN study. International Journal
of Stroke, 14(1), 69–79. http://doi.org/10.1177/1747493
018790059
Akpalu, A., Sarfo, F. S, Ovbiagele, B., Akinyemi, R., Gebregziabher,
M., Obiako, R., Owolabi, L., Sagoe, K., Jenkins, C., Arulogun, O.,
Adamu, S., Appiah, L. T., Adadey, M. A., Quansah, J. A., Mensah,
Y. B., Adeoye, A. M., Singh, A., Tosin, A. O., Ohifemen, O.,
Owolabi, M., . . . on behalf of SIREN as part of the H3Africa
Consortium. (2015). Phenotyping stroke in Sub-Saharan Africa:
Stroke investigative research and education network (SIREN) phe-
nomics protocol. Neuroepidemiology, 45(2), 73–82. http://doi.org/
10.1159/000437372
Bledsoe, M. J. (2017). Ethical legal and social issues of biobanking:
Past, present, and future. Biopreservation and Biobanking, 15(2),
142–147. http://doi.org/10.1089/bio.2017.0030
Akinyemi et al. 11
Collins, F. S., & Varmus, H. (2015). A new initiative on precision
medicine. New England Journal of Medicine, 372(9), 793–795.
http://doi.org/10.1056/NEJMp1500523
Coughlin, S., & Jenkins, C. (2017). Engaging communities in transla-
tional research. In S. S. Coughlin, S. A. Smith, & M. E. Fernandez
(Eds.), Handbook of community-based participatory research.
Oxford University Press.
de Vries, J., Munung, S. N., Matimba, A., McCurdy, S., Ouwe Missi
Oukem-Boyer, O., Staunton, C., Yakubu, A., & Tindana, P., & the
H3 Africa Consortium. (2017). Regulation of genomic and bio-
banking research in Africa: A content analysis of ethics guidelines,
policies and procedures from 22 African countries. BMC Medical
Ethics, 18(1), 8. http://doi.org/10.1186/s12910-016-0165-6
de Vries, J., Munung, S. N., & Tindana, P. (2016). Deliberation to
promote shared sovereignty in health research: Four questions to
clarify goals, methods, and scope. American Journal of Bioethics,
16(10), 50–52. http://doi.org/10.1080/15265161.2016.1214326
Doak, C., Doak, L., Miller, K., &Wilder, L. (1994). Suitability assess-
ment of materials (SAM). American Public Health Association.
Ezejimofor, M. C., Uthman, O. A., Maduka, O., Ezeabasili, A. C.,
Onwuchekwa, A. C., Ezejimofor, B. C., Asuquo, E., Chen, Y. F.,
Stranges, S., & Kandala, N. B. (2017). Stroke survivors in Nigeria:
A door-to-door prevalence survey from the Niger Delta region.
Journal of the Neurological Sciences, 372, 262–269. http://doi.
org/10.1016/j.jns.2016.11.059
Glasgow, R. E., & Estabrooks, P. E. (2018). Pragmatic applications of
RE-AIM for health care initiatives in community and clinical set-
tings. Preventing Chronic Disease, 15, E02. http://doi.org/10.
5888/pcd15.170271
Green, L. W., Richard, L., & Potvin, L. (1996). Ecological founda-
tions of health promotion. American Journal of Health Promotion,
10(4), 270–281. http://doi.org/10.4278/0890-1171-10.4.270
Guidance Tools for Community Advisory Boards. (2012). Interna-
tional AIDS vaccine initiative. http://www.iavi.org
Harden, S. M., Smith, M. L., Ory, M. G., Smith-Ray, R. L., Estab-
rooks, P. A., & Glasgow, R. E. (2018). RE-AIM in clinical, com-
munity, and corporate settings: Perspectives, strategies, and
recommendations to enhance public health impact. Frontiers in
Public Health, 6, 71. http://doi.org/10.3389/fpubh.2018.00071
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., &
Conde, J. G. (2009). Research electronic data capture (RED-
Cap)—A metadata-driven methodology and workflow process for
providing translational research informatics support. Journal of
Biomedical Informatics, 42(2), 377–381. http://doi.org/10.1016/j.
jbi.2008.08.010
Hewitt, R. E. (2011). Biobanking: The foundation of personalized
medicine. Current Opinion in Oncology, 23(1), 112–119. http://
doi.org/10.1097/CCO.0b013e32834161b8
Higginbottom, G. M., Pillay, J. J., & Boadu, N. Y. (2013). Guidance
on performing focused ethnographies with an emphasis on health-
care research. The Qualitative Report, 18, 1–6.
Hinman, J. D., Rost, N. S., Leung, T. W., Montaner, J., Muir, K. W.,
Brown, S., Arenillas, J. F., Feldman, E., & Liebeskind, D. S.
(2017). Principles of precision medicine in stroke. Journal of Neu-
rology, Neurosurgery, and Psychiatry, 88(1), 54–61. http://doi.org/
10.1136/jnnp-2016-314587
Igbe, M. A., & Adebamowo, C. A. (2012). Qualitative study of knowl-
edge and attitudes to biobanking among lay persons in Nigeria.
BMC Medical Ethics, 13, 27. http://doi.org/10.1186/1472-6939-
13-27
Israel, B. A., Eng, E., Schulz, A. J., & Parker, E. A. (2013). Methods
for community-based participatory research for health (2nd ed.).
Jossey-Bass.
Jallinoja, P., & Aro, A. R. (1999). Knowledge about genes and her-
edity among Finns. New Genetics & Society, 18(101–110). http://
doi.org/10.1080/14636779908656892
Jallinoja, P., & Aro, A. R. (2000). Does knowledge make a difference?
The association between knowledge about genes and attitudes
toward gene tests. Journal of Health Communication, 5(1),
29–39. http://doi.org/10.1080/10810730050019546
Mayne, E. S., Croxton, T., & Abimiku, A. (2017). Genes for life:
Biobanking for genetic research in Africa. Biopreservation and
Biobanking, 15(2), 93–94. http://doi.org/10.1089/bio.2017.0007
Miles, M. B., Huberman, A. M., & Saldana, J. (2013).Qualitative data
analysis: A methods sourcebook (3rd ed.). SAGE Publications.
Moodley, K., Sibanda, N., February, K., & Rossouw, T. (2014). “It’s
my blood”: Ethical complexities in the use, storage and export of
biological samples: Perspectives from South African research par-
ticipants. BMC Medical Ethics, 15, 4. http://doi.org/10.1186/1472-
6939-15-4
Munung, N. S., Mayosi, B. M., & de Vries, J. (2017). Equity in
international health research collaborations in Africa: Perceptions
and expectations of African researchers. PLoS One, 12(10),
e0186237. http://doi.org/10.1371/journal.pone.0186237
Newman, S. D., Andrews, J. O., Magwood, G. S., Jenkins, C., Cox, M.
J., & Williamson, D. C. (2011). Community advisory boards in
community-based participatory research: A synthesis of best pro-
cesses. Preventing Chronic Disease, 8(3), A70.
Owolabi, M., Miranda, J. J., Yaria, J., & Ovbiagele, B. (2016). Con-
trolling cardiovascular diseases in low and middle income coun-
tries by placing proof in pragmatism. BMJ Global Health, 1(3).
http://doi.org/10.1136/bmjgh-2016-000105
Owolabi, M. O., Akarolo-Anthony, S., Akinyemi, R., Arnett, D., Geb-
regziabher, M., Jenkins, C., Tiwari, H., Arulogun, O., Akpalu, A.,
Sarfo, F. S., Obiako, R., Owolabi, L., Sagoe, K., Melikam, S.,
Adeoye, A. M., Lackland, D., Ovbiagele, B., . . . as Members of
the H3Africa Consortium. (2015). The burden of stroke in Africa:
A glance at the present and a glimpse into the future. Cardiovas-
cular Journal of Africa, 26(2 Suppl. 1), S27–38. http://doi.org/10.
5830/CVJA-2015-038
Owolabi, M. O., Akinyemi, R. O., Gebregziabher, M., Olaniyan, O.,
Salako, B. L., Arulogun, O., & Ovbiagele, B. (2014). Rando-
mized controlled trial of a multipronged intervention to improve
blood pressure control among stroke survivors in Nigeria. Inter-
national Journal of Stroke, 9(8), 1109–1116. http://doi.org/10.
1111/ijs.12331
Owolabi, M. O., Akinyemi, R. O., Hurst, S., Arulogun, O., Olaniyan,
O., Gebregziabher, M., Salako, B. L., & Ovbiagele, B. (2014).
Tailored hospital-based risk reduction to impede vascular events
after stroke (THRIVES) study: Qualitative phase protocol. Critical
Pathways in Cardiology, 13(1), 29–35. http://doi.org/10.1097/
HPC.0000000000000005
12 International Journal of Qualitative Methods
Owolabi, M. O., Peprah, E., Xu, H., Akinyemi, R., Tiwari, H. K.,
Irvin, M. R., Wahab, K. W., Arnett, D. K., & Ovbiagele, B.
(2017). Advancing stroke genomic research in the age of trans-
omics big data science: Emerging priorities and opportunities.
Journal of the Neurological Sciences, 382, 18–28. http://doi.org/
10.1016/j.jns.2017.09.021
Prince, M., Acosta, D., Ferri, C. P., Guerra, M., Huang, Y., Jacob, K.
S., Rodriguex, J. J. L., Salas, A., Sosas, A. L., Williams, J. D., &
Hall, K. S. (2011). A brief dementia screener suitable for use by
non-specialists in resource poor settings—The cross-cultural deri-
vation and validation of the brief community screening instrument
for dementia. International Journal of Geriatric Psychiatry, 26(9),
899–907. http://doi.org/10.1002/gps.2622
Rotimi, C., Abayomi, A., Abimiku, A., Adabayeri, V. M., Adeba-
mowo, C., Ademola, A. D., Adeyemo, A., Adu, D., Affolabi, D.,
Agongo, G., Ajayi, S., Akarolo-Anthony, S., Akinyemi, R.,
Akpalu, A., Alberts, M., Alonso Betancourt, O., Alzohairy, A.
M., Ameni, G., Amodu, O., Zar, H., . . . on behalf of the H3Africa
Consortium. (2014). Research capacity. Enabling the genomic rev-
olution in Africa. Science, 344(6190), 1346–1348. http://doi.org/
10.1126/science.1251546
Shenton, A. K. (2004). Strategies for ensuring trustworthiness in qua-
litative research projects. Education for information, 22(2), 63–75.
http://doi.org/10.3233/EFI-2004-22201
Srivastava, A., & Thomson, S. B. (2009). Framework analysis: A
qualitative methodology for applied policy research. Journal of
Administration and Governance, 4(2), 72–79.
Sweet, S. N., Ginis, K. A., Estabrooks, P. A., & Latimer-Cheung, A. E.
(2014). Operationalizing the RE-AIM framework to evaluate the
impact of multi-sector partnerships. Implementation Science, 9, 74.
http://doi.org/10.1186/1748-5908-9-74
Tindana, P., & de Vries, J. (2016). Broad consent for genomic research
and biobanking: Perspectives from low- and middle-income coun-
tries. Annual Review of Genomics and Human Genetics, 17,
375–393. http://doi.org/10.1146/annurev-genom-083115-022456
Tremblay, P. R. (2002). Interviewing and counseling across cultures:
Heuristics and biases. Clinical Law Review, 9(1), 373–416.
Vaught, J. (2016a). Biobanking and biosecurity initiatives in Africa.
Biopreservation and Biobanking, 14(5), 355–356. http://doi.org/
10.1089/bio.2016.29009.jjv
Vaught, J. (2016b). Biobanking comes of age: The transition to
biospecimen science. Annual Review of Pharmacology and Toxi-
cology, 56, 211–228. http://doi.org/10.1146/annurev-pharmtox-
010715-103246
Weintraub, D., Maliski, S. L., Fink, A., Choe, S., & Litwin, M. S.
(2004). Suitability of prostate cancer education materials: Apply-
ing a standardized assessment tool to currently available materials.
Patient Education and Counseling, 55, 275–280. http://doi.org/10.
1016/j.pec.2003.10.003
Wells, K., Miranda, J., Bruce, M. L., Alegria, M., & Wallerstein, N.
(2004). Bridging community intervention and mental health ser-
vices research. American Journal of Psychiatry, 161(6), 955–963.
http://doi.org/10.1176/appi.ajp.161.6.955
Wight, D., Wimbush, E., Jepson, R., & Doi, L. (2016). Six steps in
quality intervention development (6SQuID). Journal of Epidemiol-
ogy and Community Health, 70(5), 520–525. http://doi.org/10.113
6/jech-2015-205952
Willis, G. B. (2004). Cognitive interviewing revisited: A useful tech-
nique, in theory? In S. Presser, J. M. Rothgeb, M. P. Couper, J. T.
Lessler, E. Martin, J. Martin, & E. Singer (Eds.), Methods for
testing and evaluating survey questionnaires (pp. 23–43). John
Wiley & Sons.
Willis, G. B., & Miller, K. (2011). Cross-cultural cognitive inter-
viewing: Seeking comparability and enhancing understanding.
Field Methods, 23(4), 331–341. http://doi.org/10.1177/152582
2X11416092
Xu, H., Mitchell, B. D., Peprah, E., Kittner, S. J., & Cole, J. W. (2017).
The importance of conducting stroke genomics research in African
ancestry populations. Global Heart, 12(2), 163–168. http://doi.org/
10.1016/j.gheart.2017.01.004
Yamamoto, K., Hachiya, T., Fukushima, A., Nakaya, N., Okayama, A.,
Tanno, K., Aizawa, F., Tokutomi, T., Hozawa, A., & Shimizu, A.
(2017). Population-based biobank participants’ preferences for
receiving genetic test results. Journal of Human Geneticist,
62(12), 1037–1048. http://doi.org/10.1038/jhg.2017.81
Young, O. R., Berkhout, F., Gallopin, G. C., Janssen, M. A., Ostrom,
E., & van der Leeuw, S. (2006). The globalization of socio-
ecological systems: An agenda for scientific research.Global Envi-
ronmental Change, 16, 304–316. http://doi.org/10.1016/j.gloenv
cha.2006.03.004
Akinyemi et al. 13
